UnknownPhase 4

Transplanting Hepatitis C Positive Organs

United States148 participantsStarted 2017-03-01

Plain-language summary

This is an open-label, pilot safety and efficacy trial for adults who are active on the heart, lung, or kidney transplantation lists and are eligible to receive an organ from an increased risk donor who has evidence of active or prior hepatitis C infection (HCV).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women who are age ≥ 18 years * Active on either the cardiac, lung, or kidney transplant waiting list * Willing and able to provide written informed consent to receive organs from an increased risk donor with a known transmissible infection Exclusion Criteria: * Hepatitis B NAT or viral load positive * Evidence of cirrhosis or clinically significant liver disease

What they're measuring

Graft survival

Timeframe: 6 months post-transplant

HCV status of the transplant recipient

Timeframe: 6 months post-transplant

Trial details

NCT IDNCT03086044

SponsorBrigham and Women's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12

Contact for this trial

Ann Woolley, MD

617-732-5500 awoolley@bwh.harvard.edu

View on ClinicalTrials.gov More Hepatitis C trials